The FDA approves alexinib as an adjuvant treatment for non-small cell lung cancer.

Published Date: 22 Apr 2024

Compared to chemotherapy, the ALK inhibitor lowered the risk of death or recurrence by 76%.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

We don't all need regular skin cancer screening?but you can know your risk and check yourself

2.

A computer-aided diagnostic system for improved detection of breast cancer.

3.

Cancer Patients Are Receiving More and More Stupid Immunotherapy.

4.

Dual imaging capsule captures 3D tissue and blood vessel changes for early esophageal cancer diagnosis

5.

Tumor characteristics found to differ for melanomas in children, teens and young adults


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot